Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nataliia V. Glukhoedova"'
Autor:
Elena V. Tsyganova, Nataliia V. Glukhoedova, Aleksandra S. Zhilenkova, Tatiana I. Fedoseeva, Elena N. Iushchuk, Natalia S. Smetneva
Publikováno v:
Терапевтический архив, Vol 93, Iss 9, Pp 1091-1099 (2021)
The article provides an overview of current information on the pathogenesis of COVID-19 and organ-specific lesions developing in this disease. The data on inflammation and its biochemical markers, on the features of coagulopathy, endothelial damage a
Externí odkaz:
https://doaj.org/article/0022e73324bf41228f86e34cf32f2f31
Autor:
Vladimir A. Gushchin, Elena V. Tsyganova, Darya A. Ogarkova, Ruslan R. Adgamov, Dmitry V. Shcheblyakov, Nataliia V. Glukhoedova, Aleksandra S. Zhilenkova, Alexey G. Kolotii, Roman D. Zaitsev, Denis Y. Logunov, Alexander L. Gintsburg, Alexey I. Mazus
Publikováno v:
EClinicalMedicine, Vol 46, Iss , Pp 101360- (2022)
Summary: Background: HIV-infection is known to aggravate the course of many infectious diseases, including COVID-19. International guidance recommends vaccination of HIV+ individuals against SARS-CoV-2. There is a paucity of data on epidemiological e
Externí odkaz:
https://doaj.org/article/eaf2e89c3105461ca7f3ea16d836bea0
Autor:
Nataliia V. Glukhoedova, Natalia S. Smetneva, Aleksandra S. Zhilenkova, Elena N. Iushchuk, Tatiana I. Fedoseeva, Elena V. Tsyganova
Publikováno v:
Терапевтический архив, Vol 93, Iss 9, Pp 1091-1099 (2021)
The article provides an overview of current information on the pathogenesis of COVID-19 and organ-specific lesions developing in this disease. The data on inflammation and its biochemical markers, on the features of coagulopathy, endothelial damage a
Autor:
R. R. Adgamov, Alexey G. Kolotii, Alexey Mazus, Roman D. Zaitsev, Vladimir A. Gushchin, Dmitry V. Shcheblyakov, Aleksandra S. Zhilenkova, Alexander L. Gintsburg, Nataliia V. Glukhoedova, Denis Y. Logunov, Elena V. Tsyganova, Darya A. Ogarkova
Publikováno v:
SSRN Electronic Journal.
Background: HIV infection is a known factor that aggravates the clinical course of many infectious diseases including COVID-19. The international guidance suggests that benefits from preventive SARS-CoV-2 vaccination using products with proven effica